Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,816.03 -5.62 -0.20%
FTSE 100 6,814.63 +10.76 0.16%
DAX 8,471.50 -0.70 -0.01%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Telik Inc

+ Add to Watchlist

TELK:US

1.3650 USD 0.0050 0.37%

As of 20:10:00 ET on 05/21/2013.

Company Profile for Telik Inc (TELK)

Telik, Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecule drugs to treat serious diseases. The Company's most advanced product development programs are for the treatment of cancer and diabetes.

Contact Information

Telik Inc

3165 Porter Drive
Palo Alto, CA 94304
United States
Phone: 1-650-845-7700
Fax: 1-650-845-7800

Key Executives for Telik Inc (TELK)

Michael M WickChairman/President/CEOGail L BrownSenior VP/Chief Medical Ofcr
Wendy K WeeVP:Finance/ControllerWilliam P KaplanVP:Legal Affairs/Secy/Gen Cnsl
Steven R SchowVP:Research

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil